Transplacental effects of allopurinol on suppression of oxygen free radical production in chronically instrumented fetal lamb brains during intermittent umbilical cord occlusion

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 18, Issue 1, 2005, Pages 1-7

  Masaoka, Naoki ^a,b   Nakajima, Yoshiyuki ^a   Hayakawa, Yasuhito ^a   Ohgame, Sachiko ^a   Hamano, Satoshi ^a   Nagaishi, Masaji ^a   Yamamoto, Tatsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Allopurinol; Fetal brain damage; Oxygen free radicals; Umbilical cord; Xanthine oxidase

Indexed keywords

ALLOPURINOL; OXIPURINOL; OXYGEN RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG TRANSPORT; FETUS; FETUS HYPOXIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LAMB; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; UMBILICAL CORD; UMBILICAL CORD OBSTRUCTION;

ALLOPURINOL; ANIMALS; BRAIN; ENZYME INHIBITORS; FEMALE; FETAL HYPOXIA; FETUS; FREE RADICAL SCAVENGERS; OXIDATIVE STRESS; OXYPURINOL; PLACENTA; PREGNANCY; REACTIVE OXYGEN SPECIES; SHEEP; SUPEROXIDES; UMBILICAL CORD; XANTHINE OXIDASE;

EID: 24044518724     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500127716     Document Type: Article

References (32)

1. Freeman J, Nelson K Intrapartum asphyxia and cerebral palsy. Pediatrics 1988;82:240-249.
2. Blair E, Stanley F. Intrapartum asphyxia: A rare cause of cerebral palsy. J Pediatr 1988;112:515-519.
3. Clapp JF, Peress NS, Wesley M, et al. Brain damage after intermittent partial cord occlusion in the chronically instrumented fetal lambs. Am J Obstet Gynecol 1988;159:504-509.
4. De Haan HH, Gunn AJ, Williams CE, et al. Brief repeated umbilical cord occlusions cause sustained cytotoxic cerebral edema and focal infarcts in near-term fetal lambs. Pediatr Res 1997;41:96-104.
5. Masaoka N, Hayakawa Y, Ohgame S, et al. Changes in purine metabolism and production of oxygen free radicals by intermittent partial umbilical cord occlusion in chronically instrumented fetal lambs. J Obstet Gynecol Res 1998;24:63-71.
6. Palmer C. Hypoxic-ischemic encephalopathy: Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals. Clin Perinatol 1995;22:481-517.
7. Pourcyrous M, Leffler CW, Bada HS, et al. Brain superoxide anion generation in asphyxiated piglets and the effect of indomethacin at therapeutic dose. Pediatr Res. 1993;34:366-369.
8. Betz AL. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J Neurochem 1985;44:574-579.
9. Gluckman PD, Williams CE. Is the cure worse than the disease? Caveats in the move from laboratory to clinic. Dev Med Child Neurol 1992;34:1015-1018.
10. Palmer C, Vanucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990;27:332-336.
11. Palmer C, Smith MB, Williams CD, et al. Allopurinol preserves cerebral energy metabolism during perinatal hypoxic-ischemic injury and reduces brain damage in a dose dependent manner. J Cereb Blood Flow Metab 1991; 11:S144-S149.
12. Moonhouse PC, Grootvelt M, Halliwell B, et al. Allopurinol and oxypurinol are hydroxyl radical scavenger. FEBS Lett 1987;21:23-28.
13. Ko KM, Godin DV. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 1990;40: 803-809.
14. Boda D, Nemeth I, Hencz P, et al. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Dev Pharmacol Ther 1984;7:357-367.
15. Russel GAB., Cooke RWI. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child 1995;73:F27-F31.
16. Marro PJ, Baumgart S, Delivoria-Papadopoulas M, et al. Purine metabolism and inhibition of xanthine oxidase in severly hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatr Res 1997;41:513-520.
17. Palmer C, Towfighi J, Roberts SL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces injury in 7-day-old rats. Pediatr Res 1993;33:405-409.
18. Palmer C, Roberts RL. Delayed administration of allopurinol after cerebral hypoxia-ischemia reduced brain injury in neonatal rats. Pediatr Res 1994;41:294A.
19. Frank VB, Majidah S, Ralf MW, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185-193.
20. Shadis M, Moison R, Steendijk P, et al. The effect of antioxidative combination therapy on post hypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain. Pediatr Res, 44:119-124.
21. Marron PJ, Hoffmann D, Schneiderman R, et al. Effect of allopurinol on NMDA receptor modification following recurrent asphyxia in newborn piglets. Brain Res 1998;16:71-77.
22. Shadid M, Buonocore G, Groenendaal F, et al. Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci Lett 1988,22:5-8.
23. Marro PJ, Anderson CB, Mishra OP, et al. Effect of allopurinol on hypoxia-induced modification of the NMDA receptor in newborn piglets. Neurochem Res 1999;24:1301-1306.
24. Whitelaw A. Systematic review of therapy after hypoxic-ischemic brain injury in the perinatal period. Semin Neonatol 2000;5:33-40.
25. Terzi C, Kuzu A, Asiar AK, et al. Prevention of deleterious effects of reperfusion injury using one-week high-dose allopurinol. Dig Dis Sci 2001;46:430-437.
26. Akdemir H, Asik Z, Pasaoglu H, et al. The effect of allopurinol on focal cerebral ischemia: An experimental study in rabbits. Neurosurg Rev 2001;24:131-135.
27. Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 2002;9:195-217.
28. Peeters-Scholte C, Vant Den Tweel E, Iorol T. et al. Pharmacological interventions in the newborn piglet in the first 24 h after hypoxia-ischemia: A hemodynamic and eletrophysiological perspective. Exp Brain Res 2002; 147: 200-208.
29. Whitelaw A, Thoresen M. Clinical trial of treatment after perinatal asphyxia. Curr Opin Pediatr 2002;14:664-668.
30. Kann HE, Wells JH, Galleli JF, et al. The development and use of an intravenous preparation of allopurinol. Am J Med Sci 1968;256:53-63.
31. Saliba E, Marret S. Cerebral white matter damage in the preterm infant: Pathophysiology and risk factors. Semin Neonatol 2001;6:121-133.
32. Takashima S, Tanaka K. Development of cerebrovasucular architecture and its relationship to periventricular leukomalacia. Arch Neurol 1995;35:11-16.